Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Natural Relief Inc.
WARNING LETTER
•Natural Relief Inc.•April 14, 2023

Natural Relief Inc. – FDA Warning Letter, Apr 14, 2023

Record Details

The FDA inspected NatRelief's facility from March 14 to April 14, 2023, and reviewed their website, identifying serious violations. The products Edema NatRelief 6 and BP NatRelief 11 are deemed unapproved new drugs and misbranded. Claims on the website establish them as drugs intended for disease treatment, making them "new drugs" requiring FDA approval, which they lack. BP NatRelief 11 is also misbranded as it lacks adequate directions for layperson use, being a prescription-only drug.

Furthermore, even if not unapproved drugs, these products are adulterated dietary supplements due to serious Current Good Manufacturing Practice (CGMP) violations under 21 CFR Part 111. Violations include failure to establish specifications for components (identity, purity, strength, contamination limits), in-process specifications (e.g., particle size), and finished product specifications. The company also failed to establish and follow written procedures for quality control operations, master manufacturing records, batch production records, holding and distribution, returned dietary supplements, and equipment cleaning/sanitizing.

Additionally, Edema NatRelief 6 and BP NatRelief 11 are misbranded dietary supplements under section 403 of the Act due to incorrect serving sizes and improper nutrition information presentation on labels. The FDA noted the company's May 5, 2023, response was insufficient as it lacked

Company
Natural Relief Inc.
Inspection date
April 14, 2023
Product type
Food
Office
Division of Human and Animal Food Operations - East V
People
  • Ana Morales
  • Kimberly L. McMillan (Acting Program Director)
View Company Profile

ID · 22359ca8-cee6-4137-b427-4db0724f794f

Violation Codes10
21 CFR 101.921 CFR 111.10321 U.S.C. 343(q)(5)(F)FD&C Act 402(g)(1)21 CFR 101.421 CFR 101.12(b)21 CFR 111.26021 CFR 101.3621 CFR 111.70(b)(1)21 CFR 111.70(b)(3)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Natural Relief Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.